Evaluation of the safety and tolerability of a nutritional Formulation in patients with ANgelman Syndrome (FANS): study protocol for a randomized controlled trial.
Autorzy:
Herber DL; Disruptive Nutrition, LLC, 300 West Morgan Street, Suite 1510, Durham, NC, 27701, USA. WeeberEJ; PTC Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ, 07080-2449, USA. D'Agostino DP; Morsani College of Medicine, Department of Molecular Pharmacology and Physiology, University of South Florida, 12901 Bruce B Downs Blvd, Tampa, FL, 33612, USA.; Institute for Human and Machine Cognition, Ocala, FL, USA. Duis J; Division of Medical Genetics & Genomic Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, 37232-2578, USA. .
Pokaż więcej
Źródło:
Trials [Trials] 2020 Jan 09; Vol. 21 (1), pp. 60. Date of Electronic Publication: 2020 Jan 09.
Sandusky-Beltran LA; Byrd Alzheimer's Institute, Department of Pharmaceutical Sciences, University of South Florida, 4001 E. Fletcher Ave, Tampa, FL, 33613, USA.; Neuroscience Institute, Department of Neuroscience and Physiology, New York University School of Medicine, 1 Park Avenue, New York, NY, 10016, USA. Kovalenko A; Byrd Alzheimer's Institute, Department of Pharmaceutical Sciences, University of South Florida, 4001 E. Fletcher Ave, Tampa, FL, 33613, USA. Ma C; Byrd Alzheimer's Institute, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, 33613, USA. Calahatian JIT; Byrd Alzheimer's Institute, Department of Pharmaceutical Sciences, University of South Florida, 4001 E. Fletcher Ave, Tampa, FL, 33613, USA. Placides DS; Byrd Alzheimer's Institute, Department of Pharmaceutical Sciences, University of South Florida, 4001 E. Fletcher Ave, Tampa, FL, 33613, USA. Watler MD; Byrd Alzheimer's Institute, Department of Pharmaceutical Sciences, University of South Florida, 4001 E. Fletcher Ave, Tampa, FL, 33613, USA. Hunt JB; Byrd Alzheimer's Institute, Department of Pharmaceutical Sciences, University of South Florida, 4001 E. Fletcher Ave, Tampa, FL, 33613, USA. Darling AL; Byrd Alzheimer's Institute, Department of Molecular Medicine, University of South Florida, Tampa, FL, 33613, USA. Baker JD; Byrd Alzheimer's Institute, Department of Molecular Medicine, University of South Florida, Tampa, FL, 33613, USA. Blair LJ; Byrd Alzheimer's Institute, Department of Molecular Medicine, University of South Florida, Tampa, FL, 33613, USA. Martin MD; Byrd Alzheimer's Institute, Department of Molecular Medicine, University of South Florida, Tampa, FL, 33613, USA. Fontaine SN; Byrd Alzheimer's Institute, Department of Molecular Medicine, University of South Florida, Tampa, FL, 33613, USA. Dickey CA; Byrd Alzheimer's Institute, Department of Molecular Medicine, University of South Florida, Tampa, FL, 33613, USA. Lussier AL; Byrd Alzheimer's Institute, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, 33613, USA. WeeberEJ; Byrd Alzheimer's Institute, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, 33613, USA. Selenica MB; Byrd Alzheimer's Institute, Department of Pharmaceutical Sciences, University of South Florida, 4001 E. Fletcher Ave, Tampa, FL, 33613, USA. Nash KR; Byrd Alzheimer's Institute, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, 33613, USA. Gordon MN; Byrd Alzheimer's Institute, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, 33613, USA.; Department of Translational Science & Molecular Medicine, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI, 49503, USA. Morgan D; Byrd Alzheimer's Institute, Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, 33613, USA.; Department of Translational Science & Molecular Medicine, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI, 49503, USA. Lee DC; Byrd Alzheimer's Institute, Department of Pharmaceutical Sciences, University of South Florida, 4001 E. Fletcher Ave, Tampa, FL, 33613, USA. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2019 Jun 29; Vol. 11 (1), pp. 58. Date of Electronic Publication: 2019 Jun 29.
Identification of spatiotemporal gait parameters and pressure-related characteristics in children with Angelman syndrome: A pilot study.
Autorzy:
Grieco JC; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida. Gouelle A; Gait & Balance Academy, ProtoKinetics, Gometz-le-Châtel, France.; UFR STAPS de Reims, Laboratoire Performance, Santé, Métrologie, Société (PSMS, EA 7507), Reims, France. WeeberEJ; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Quantitative Measurement of Communication Ability in Children with Angelman Syndrome.
Autorzy:
Grieco JC; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA. Bahr RH; Department of Communication Sciences and Disorders, University of South Florida, Tampa, FL, USA. Schoenberg MR; Department of Neuropsychology and Psychiatry, University of South Florida, Tampa, FL, USA. Conover L; Department of Communication Sciences and Disorders, University of South Florida, Tampa, FL, USA. Mackie LN; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA. WeeberEJ; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome.
Autorzy:
Hethorn WR; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. Ciarlone SL; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. Filonova I; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. Rogers JT; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. Aguirre D; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. Ramirez RA; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. Grieco JC; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. Peters MM; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. Gulick D; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Medicine, University of South Florida, Tampa, FL, USA. Anderson AE; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. L Banko J; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Medicine, University of South Florida, Tampa, FL, USA. Lussier AL; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA. WeeberEJ; USF Health Byrd Alzheimer's Institute, 4001 East Fletcher Avenue, Tampa, FL, 33613, USA.; Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA.
An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome.
Autorzy:
Grieco JC; Department of Molecular Pharmacology and Physiology, University of South Florida, Morsani College of Medicine, 12901 Bruce B Downs Boulevard, Tampa, FL, 33612, USA. . Ciarlone SL; Department of Molecular Pharmacology and Physiology, University of South Florida, Morsani College of Medicine, 12901 Bruce B Downs Boulevard, Tampa, FL, 33612, USA. . Gieron-Korthals M; Department of Pediatrics, University of South Florida, Morsani College of Medicine, 12901 Bruce B Downs Boulevard, Tampa, FL, 33612, USA. .; Department of Neurology, University of South Florida, Morsani College of Medicine, 12901 Bruce B Downs Boulevard, Tampa, FL, 33612, USA. . Schoenberg MR; Departments of Psychiatry and Behavioral Neurosciences, University of South Florida, Morsani College of Medicine, 12901 Bruce B Downs Boulevard, Tampa, FL, 33612, USA. .; Department of Neurology, University of South Florida, Morsani College of Medicine, 12901 Bruce B Downs Boulevard, Tampa, FL, 33612, USA. .; University of South Florida Health's Byrd Alzheimer's Research Institute, 4001 E Fletcher Avenue, Tampa, FL, 33613, USA. . Smith AG; University of South Florida Health's Byrd Alzheimer's Research Institute, 4001 E Fletcher Avenue, Tampa, FL, 33613, USA. . Philpot RM; Departments of Psychiatry and Behavioral Neurosciences, University of South Florida, Morsani College of Medicine, 12901 Bruce B Downs Boulevard, Tampa, FL, 33612, USA. . Heussler HS; Mater Research Institute, University of Queensland, St Lucia, QLD, 4072, Australia. . Banko JL; University of South Florida Health's Byrd Alzheimer's Research Institute, 4001 E Fletcher Avenue, Tampa, FL, 33613, USA. . WeeberEJ; Department of Molecular Pharmacology and Physiology, University of South Florida, Morsani College of Medicine, 12901 Bruce B Downs Boulevard, Tampa, FL, 33612, USA. .; University of South Florida Health's Byrd Alzheimer's Research Institute, 4001 E Fletcher Avenue, Tampa, FL, 33613, USA. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2014 Dec 10; Vol. 14, pp. 232. Date of Electronic Publication: 2014 Dec 10.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Fyn tyrosine kinase increases Apolipoprotein E Receptor 2 levels and phosphorylation.
Autorzy:
Burrell TC; Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, United States of America. Divekar SD; Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, United States of America. WeeberEJ; Department of Molecular Pharmacology and Physiology, University of South Florida Health Byrd Alzheimer's Institute, University of South Florida, Tampa, Florida, United States of America. Rebeck GW; Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Oct 23; Vol. 9 (10), pp. e110845. Date of Electronic Publication: 2014 Oct 23 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Similarities and differences in structure, expression, and functions of VLDLR and ApoER2.
Autorzy:
Reddy SS; Department of Neuroscience; Georgetown University Medical Center, 3970 Reservoir Rd, NW, Washington, DC, 20007, USA. . Connor TE WeeberEJ Rebeck W
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2011 May 09; Vol. 6, pp. 30. Date of Electronic Publication: 2011 May 09.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
